Literature DB >> 26355893

Alternate PAX3-FOXO1 oncogenic fusion in biphenotypic sinonasal sarcoma.

Waihay J Wong1, Alexandra Lauria1, Jason L Hornick1, Sheng Xiao1, Jonathan A Fletcher1, Adrian Marino-Enriquez1.   

Abstract

Biphenotypic sinonasal sarcoma (SNS) is a low grade spindle cell sarcoma that affects middle-aged adults, in which the PAX3-MAML3 chimeric transcription factor induces an aberrant dual myogenic and neuroectodermal phenotype. We report an alternate PAX3-FOXO1 oncogenic fusion in SNS, confirming the crucial role of PAX3 in SNS oncogenesis. The presence of PAX3-FOXO1 in SNS and alveolar rhabdomyosarcoma suggests that these two entities are genetically similar lesions arising from distinct progenitor cell pools. This finding has important implications for the molecular diagnosis of SNS and alveolar rhabdomyosarcoma, and underscores the critical contribution of the cell of origin to the phenotype induced by oncogenic transcription factor reprogramming.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26355893      PMCID: PMC4919599          DOI: 10.1002/gcc.22295

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  11 in total

1.  Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo.

Authors:  Christian Mosimann; George Hausmann; Konrad Basler
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

2.  Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma.

Authors:  Xiaoke Wang; Krista L Bledsoe; Rondell P Graham; Yan W Asmann; David S Viswanatha; Jean E Lewis; Jason T Lewis; Margaret M Chou; Michael J Yaszemski; Jin Jen; Jennifer J Westendorf; André M Oliveira
Journal:  Nat Genet       Date:  2014-05-25       Impact factor: 38.330

Review 3.  Synovial sarcoma.

Authors:  C Fisher
Journal:  Ann Diagn Pathol       Date:  1998-12       Impact factor: 2.090

Review 4.  The emerging complexity of gene fusions in cancer.

Authors:  Fredrik Mertens; Bertil Johansson; Thoas Fioretos; Felix Mitelman
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

5.  PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.

Authors:  Poul H B Sorensen; James C Lynch; Stephen J Qualman; Roberto Tirabosco; Jerian F Lim; Harold M Maurer; Julia A Bridge; William M Crist; Timothy J Triche; Frederic G Barr
Journal:  J Clin Oncol       Date:  2002-06-01       Impact factor: 44.544

6.  Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.

Authors:  Charles Keller; Mark S Hansen; Cheryl M Coffin; Mario R Capecchi
Journal:  Genes Dev       Date:  2004-11-01       Impact factor: 11.361

7.  Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.

Authors:  Charles Keller; Benjamin R Arenkiel; Cheryl M Coffin; Nabeel El-Bardeesy; Ronald A DePinho; Mario R Capecchi
Journal:  Genes Dev       Date:  2004-10-15       Impact factor: 11.361

8.  Malignant peripheral nerve sheath tumors with divergent differentiation.

Authors:  B S Ducatman; B W Scheithauer
Journal:  Cancer       Date:  1984-09-15       Impact factor: 6.860

9.  Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma.

Authors:  N Galili; R J Davis; W J Fredericks; S Mukhopadhyay; F J Rauscher; B S Emanuel; G Rovera; F G Barr
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

10.  High expression of the PAX3-FKHR oncoprotein is required to promote tumorigenesis of human myoblasts.

Authors:  Shujuan J Xia; Dara D Holder; Bruce R Pawel; Chune Zhang; Frederic G Barr
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

View more
  13 in total

Review 1.  Biphenotypic sinonasal sarcoma: demographics, clinicopathological characteristics, molecular features, and prognosis of a recently described entity.

Authors:  Simon Andreasen; Justin A Bishop; Henrik Hellquist; Jennifer Hunt; Katalin Kiss; Alessandra Rinaldo; Alena Skálová; Stefan M Willems; Michelle Williams; Alfio Ferlito
Journal:  Virchows Arch       Date:  2018-08-14       Impact factor: 4.064

Review 2.  Update on selected advances in the immunohistochemical and molecular genetic analysis of soft tissue tumors.

Authors:  Khin Thway; Andrew L Folpe
Journal:  Virchows Arch       Date:  2019-11-07       Impact factor: 4.064

Review 3.  New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base.

Authors:  Lester D R Thompson; Alessandro Franchi
Journal:  Virchows Arch       Date:  2017-04-25       Impact factor: 4.064

Review 4.  Imaging Review of New and Emerging Sinonasal Tumors and Tumor-Like Entities from the Fourth Edition of the World Health Organization Classification of Head and Neck Tumors.

Authors:  K E Dean; D Shatzkes; C D Phillips
Journal:  AJNR Am J Neuroradiol       Date:  2019-02-14       Impact factor: 3.825

5.  Biphenotypic Sinonasal Sarcoma-Case Report and Review of Clinicopathological Features and Diagnostic Modalities.

Authors:  Chandala Chitguppi; Ian Koszewski; Kaitlin Collura; Mark Curtis; Gurston Nyquist; Mindy Rabinowitz; Marc Rosen
Journal:  J Neurol Surg B Skull Base       Date:  2018-07-16

6.  Biphenotypic sinonasal sarcoma: an expanded immunoprofile including consistent nuclear β-catenin positivity and absence of SOX10 expression.

Authors:  Lisa M Rooper; Shih-Chiang Huang; Cristina R Antonescu; William H Westra; Justin A Bishop
Journal:  Hum Pathol       Date:  2016-04-29       Impact factor: 3.466

7.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Nasal Cavity, Paranasal Sinuses and Skull Base.

Authors:  Edward B Stelow; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2017-02-28

8.  Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum.

Authors:  François Le Loarer; Sophie Laffont; Tom Lesluyes; Franck Tirode; Cristina Antonescu; Anne-Catherine Baglin; Lucile Delespaul; Isabelle Soubeyran; Isabelle Hostein; Gaëlle Pérot; Frédéric Chibon; Jessica Baud; Sophie Le Guellec; Marie Karanian; Valérie Costes-Martineau; Claire Castain; Sandrine Eimer; Brigitte Le Bail; Michel Wassef; Jean-Michel Coindre
Journal:  Am J Surg Pathol       Date:  2019-06       Impact factor: 6.394

Review 9.  Soft Tissue Special Issue: Biphenotypic Sinonasal Sarcoma: A Review with Emphasis on Differential Diagnosis.

Authors:  John Gross; Karen Fritchie
Journal:  Head Neck Pathol       Date:  2020-01-16

10.  Fusion of the Paired Box 3 (PAX3) and Myocardin (MYOCD) Genes in Pediatric Rhabdomyosarcoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Kristin Andersen; Marius Lund-Iversen; Svetlana Tafjord; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 Nov-Dec       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.